1215071-17-2

Basic information

• Product Name: tert-butyl 3,3-difluoro-4-oxopiperidine-1-carboxylate
• Synonyms: 1-Piperidinecarboxylic acid, 3,3-difluoro-4-oxo-, 1,1-diMethylethyl ester;tert-Butyl 3,3-difluoro-4-oxopiperidin-1-carboxylate hydrate;tert-Butyl 3,3-difluoro-4-oxopiperidine-1-carboxylate hydrate;tert-Butyl 3,3-difluoro-4-oxopiperidine-1-carboxylate;1-(tert-Butyloxycarbonyl)-3,3-difluoro-4-oxopiperidine;3,3-Difluoro-4-oxo-piperidine-1-carboxylic acid tert-butyl ester;N-t-BOC-5,5-Difluoro-4-Piperidinone;EOS-61163
• CAS NO: 1215071-17-2
• Molecular Formula: C₁₀H₁₅F₂NO₃
• Molecular Weight: 235.2278064
• Mol File: 1215071-17-2.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 274.7±40.0 °C(Predicted)
• Appearance: /
• Density: 1.21±0.1 g/cm3(Predicted)
• PKA: -5?+-.0.40(Predicted)
• CAS DataBase Reference: tert-butyl 3,3-difluoro-4-oxopiperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 3,3-difluoro-4-oxopiperidine-1-carboxylate(1215071-17-2)
• EPA Substance Registry System: tert-butyl 3,3-difluoro-4-oxopiperidine-1-carboxylate(1215071-17-2)

Safety Data

• Hazardous Substances Data: 1215071-17-2(Hazardous Substances Data)

Usage

General Description

Tert-butyl 3,3-difluoro-4-oxopiperidine-1-carboxylate is a chemical compound which is specific and complex in nature. tert-butyl 3,3-difluoro-4-oxopiperidine-1-carboxylate belongs to the class of organic compounds known as Piperidinones, a sub-category of Piperidines. The structure of this chemical includes a system of a Piperidinone (a hexahydropyridine bearing an oxo substituent at any position), where a piperidin-4-one is carrying a difluoro substituent at position 3, a tert-butyl at position 1 and an oxo group. Due to its specific structure, this chemical is likely to be used primarily for research purposes and would likely need to be handled by scientists with a good understanding of chemistry because of its intricate structure.

Upstream product

• 1239596-54-3 3,3-difluoropiperidin-4-ol 
• 1239596-53-2 N-benzyl-3,3-difluoro-4-hydroxypiperidine 
• 1209780-71-1 tert-butyl 3,3-difluoro-4-hydroxy-piperidine-1-carboxylate 
• 1067914-81-1 3,3-difluoro-1-(phenylmethyl)-4,4-piperidinediol 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1039741-54-2 1-benzyl-3,3-difluoropiperidin-4-one 
• 51779-32-9 iminodicarboxylic acid di-tert-butyl ester 
• 1523618-12-3 3,3-difluoropiperidin-4-one hydrochloride 
• 1423027-29-5 1-(4-methoxybenzyl)-3,3-difluoropiperidin-4-one 
• 1423027-26-2 ethyl 5,5-difluoro-1-(4-methoxybenzyl)-4-oxopiperidine-3-carboxylate 
• 1423027-23-9 ethyl 3-[(3-ethoxy-3-oxopropyl)(4-methoxybenzyl)amino]-2,2-difluoropropanoate 

Downstream Products

• 1334412-95-1 tert-butyl 4-(2-ethoxy-2-oxoethyl)-3,3-difluoropiperidine-1-carboxylate 
• 1429256-79-0 C₁₆H₁₉BrF₂N₂O₂ 
• 1429256-80-3 C₁₇H₂₁BrF₂N₂O₂ 
• 1429256-81-4 C₁₇H₂₁BrF₂N₂O₂ 
• 1429256-82-5 C₁₇H₂₁BrF₂N₂O₂ 
• 1429256-83-6 C₁₉H₂₅BrF₂N₂O₂ 
• 1039741-54-2 1-benzyl-3,3-difluoropiperidin-4-one 
• 1373503-54-8 (±)-2-(1-( tert-butoxycarbonyl)-3,3-difluoropiperidin-4-yl)acetic acid 

Relevant articles and documents

COMPOUNDS USEFUL AS KINASE INHIBITORS

This invention relates to novel compounds. The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK).The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia and immunological diseases.

Bridged Spiro[2.4]heptane Ester Derivatives

The invention relates to a method for preparing linear polymers having an amide end or having a star architecture comprising an amide core, by means of a ring opening using lactide and glycolide monomers or a lactide monomer ring in the presence of a cata

BRIDGED SPIRO[2.4]HEPTANE ESTER DERIVATIVES

The present invention relates to bridged spiro[2.4]heptane ester derivatives of formula (I) wherein W, Y, R1 and R2 are as defined in the description, their preparation and their use as pharmaceutically active compounds.